Turk Kardiyol Dern Ars. 2020; 48(2): 180-184 | DOI: 10.5543/tkda.2019.63479
Complex drug interactions in an HIV-seropositive heart transplant recipient
Isabelle Sénéchal1, Nathalie Châteauvert2, Philippe GERVAIS3, Pierre Voisine4, Michelle Dubois5, Mario Sénéchal11Department of Cardiology, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
2Department of Pharmacy, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
3Department of Infectious Disease, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
4Department of Cardiac Surgery, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
5Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
Highly active antiretroviral therapy has led to greater life expectancy for human immun-deficiency virus (HIV)-positive patients. This was a report of 11 years of follow-up of an HIV-seropositive patient who underwent heart transplantation in 2006, with emphasis on the management challenges of complex drug interactions over time.
Keywords: Drug interactions, heart transplantation; human immun-deficiency virus.
Corresponding Author: Mario Sénéchal, Canada
Manuscript Language: English